Hims & Hers has reached an agreement with Eli Lilly to offer the company’s branded weight-loss and obesity treatments through the Hims & Hers online health platform. The deal enables patients to access Lilly’s obesity medicines as part of Hims & Hers’ telehealth and wellness services.

Quartz and Fierce Healthcare both describe the partnership as a way to distribute Lilly’s treatments directly to consumers through telehealth rather than via traditional channels. The accounts differ mainly in emphasis: Quartz highlights which specific Lilly drugs are included and notes that the arrangement is for patients who pay out of pocket. Fierce Healthcare focuses more broadly on the fact that Hims & Hers will sell branded weight-loss drugs from Lilly via its platform.